- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.12. | NeurAxis files for secondary mixed shelf offering | 1 | Seeking Alpha | ||
| 10.12. | NeurAxis, Inc.: NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation | 82 | GlobeNewswire (Europe) | RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without needing electronics or software. NeurAxis Inc. will begin... ► Artikel lesen | |
| 25.11. | Neuraxis, INC - 8-K, Current Report | - | SEC Filings | ||
| 15.11. | Neuraxis, INC - 8-K, Current Report | - | SEC Filings | ||
| 12.11. | NeurAxis reports Q3 results | 1 | Seeking Alpha | ||
| NEURAXIS Aktie jetzt für 0€ handeln | |||||
| 12.11. | NeurAxis, Inc.: NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues | 213 | GlobeNewswire (Europe) | CARMEL, Ind., Nov. 12, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic... ► Artikel lesen | |
| 04.11. | NeurAxis wins expanded FDA clearance for non-implanted neurostim for pain relief | 1 | MassDevice | ||
| 04.11. | NeurAxis, Inc.: NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market | 95 | GlobeNewswire (Europe) | CARMEL, Ind., Nov. 04, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing... ► Artikel lesen | |
| 29.10. | NeurAxis, Inc.: NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024 | 1 | GlobeNewswire (USA) | ||
| 22.10. | NeurAxis, Inc.: NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation | 1 | GlobeNewswire (USA) | ||
| 18.10. | Neuraxis adjusts equity agreement, secures additional funding | 1 | Investing.com | ||
| 18.10. | Neuraxis passt Aktienvereinbarung an und sichert zusätzliche Finanzierung | 1 | Investing.com Deutsch | ||
| 18.10. | Neuraxis, INC - 8-K, Current Report | 1 | SEC Filings | ||
| 19.09. | NeurAxis, Inc.: NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 | 1 | GlobeNewswire (USA) | ||
| 13.09. | Neuraxis gibt Aktien im Rahmen einer Eigenkapitalfinanzierung aus | 1 | Investing.com Deutsch | ||
| 13.09. | Neuraxis, INC - 8-K, Current Report | 1 | SEC Filings | ||
| 27.08. | NeurAxis, Inc.: NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024 | 1 | GlobeNewswire (USA) | ||
| 22.08. | Neuraxis shareholders approve key proposals at annual meeting | 1 | Investing.com | ||
| 21.08. | Neuraxis, INC - 8-K, Current Report | 1 | SEC Filings | ||
| 13.08. | NeurAxis, Inc.: NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024 | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
Das Unternehmen NEURAXIS INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 2,560 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEURAXIS INC finden Sie auf Wallstreet Online.
